Legislation Details

File #: Res 0211-2018    Version: * Name: Declaring the last day in February as Rare Disease Day in NYC.
Type: Resolution Status: Filed (End of Session)
File created: 3/7/2018 In control: Committee on Health
On agenda: 3/7/2018 Final action: 12/31/2021
Title: Resolution declaring the last day in February as Rare Disease Day in New York City.
Sponsors: Mathieu Eugene
Attachments: 1. Res. No. 211, 2. March 7, 2018 - Stated Meeting Agenda, 3. Hearing Transcript - Stated Meeting 03-07-18, 4. Minutes of the Stated Meeting - March 7, 2018, 5. Committee Report 9/9/19, 6. Hearing Testimony 9/9/19, 7. Hearing Transcript 9/9/19
Res. No. 211

Title
Resolution declaring the last day in February as Rare Disease Day in New York City.
Body

By Council Member Eugene
Whereas, According to Global Genes, a rare disease patient advocacy organization based in California, a disease is considered rare in the United States (U.S.) if it affects fewer than 200,000 persons; and
Whereas, There are approximately 7,000 different types of rare diseases and disorders; and
Whereas, Ten percent of the U.S. population, or 30 million people, are living with rare diseases and it is estimated that 350 million people worldwide suffer from rare diseases; and
Whereas, Eighty percent of rare diseases are genetic and approximately 50% of the people affected by rare diseases are children; and
Whereas, Rare diseases are often prevalent in pockets of ethnic minorities due to their genetic origin; and
Whereas, For example, sickle cell anemia is rare globally but an estimated 1 in 11 African Americans is a carrier and a person of 100% Ashkenazi Jewish descent has a 50% chance of carrying one of several rare genetic diseases, according to the Genetic Disease Foundation; and
Whereas, According to an April 2013 Shire Rare Disease Impact Report, it takes an average of 7.6 years in the U.S. for a patient with a rare disease to receive a proper diagnosis; and
Whereas, A patient typically visits up to eight physicians and receives two to three misdiagnoses before the correct diagnosis is made; and
Whereas, The Shire report finds that rare disease patients in the U.S. face considerable financial hardship, including 55% of survey respondents stating that direct medical expenses were not covered by insurance, 37% had to borrow money from family and/or friends to pay for expenses, 34 percent sought help from charity or public assistance and 32% reported a negative impact on their credit score; and
Whereas, The economic strains and lengthy diagnosis process, as well as the...

Click here for full text